A ten-gene DNA-damage response pathway gene expression signature predicts gemtuzumab ozogamicin response in pediatric AML patients treated on COGAAML0531 and AAML03P1 trials
暂无分享,去创建一个
R. Ries | S. Meshinchi | T. Alonzo | B. Hirsch | Vivek M. Shastri | J. Lamba | A. Gamis | A. H. Elsayed | Yi-Cheng Wang | Nam H K Nguyen | Nam H. K. Nguyen | M. Gbadamosi | Alice Dang | Oluwaseyi Olabige | Angelica De Jesus